Industry Leader Dr. Reddy Gottipolu joins One Network Enterprises as SVP Healthcare to Accelerate Sector Growth

One Network Enterprises, a leader in supply chain network technology, recently announced that Dr. Reddy Gottipolu has joined the company as its SVP Healthcare, effective immediately. In this newly created role, Dr. Gottipolu will provide leadership focused on delivering network-based value across the Healthcare Industry Segment. Reddy will report directly to the COO, Joe Bellini, who previously oversaw this segment.

“I am thrilled to welcome Reddy to our executive team and look forward to leveraging his deep healthcare knowledge along with his business experience and passion to help drive our customer success, and even more importantly drive successful patient outcomes through the deployment of our healthcare supply network,” said Joe Bellini, COO, One Network Enterprises.

“This new position is a direct result of the rapid growth in demand for One Network’s platform across the Healthcare segment, including the current customer base of providers, distributors, pharmaceutical manufacturers, and medical device distributors and manufacturers”, he added.

Dr. Gottipolu is an experienced executive and industry leader, recognized for helping hospitals and their trading partners drive supply chain excellence and innovation. Most recently, he served as the Chief Supply Chain Officer at the Memorial Hermann Health System. Prior to that, he held leadership positions at Adeptus Health, MedAssets, Fairview Health, GE Capital, and General Motors. Reddy holds a Master’s degree in Engineering from the Indian Institute of Technology Kharagpur, an MBA from Michigan State University, and a Ph.D. from the University of Montreal.

“One Network’s customers include some of the largest GPO, medical device, and pharmaceutical firms in the world, as well as global humanitarian networks,” said Dr. Reddy Gottipolu, SVP Healthcare, One Network Enterprises. “I look forward to expanding this success, even as we improve patient safety and clinical outcomes through resilient supply chain networks.”